Dr. Kourelis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2012 - 2016
- University of ConnecticutResidency, Internal Medicine, 2009 - 2012
- University of AthensClass of 2006
Certifications & Licensure
- MN State Medical License 2012 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Retreatment of multiple myeloma with previously refractory drugs.Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K Buadi
Blood Advances. 2024-12-24 - Capillary leak phenotype as a major cause of death in patients with POEMS syndrome.Kenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, Rahma Warsame, Francis Buadi
Leukemia. 2024-12-16 - Prognostic Impact of Patient-Reported Symptoms in Multiple Myeloma.Nadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, Francis K Buadi, Prashant Kapoor
Blood Advances. 2024-12-05
Journal Articles
- Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple MyelomaS Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
- Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell TransplantationNelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
- Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of RelapseAngela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
- Join now to see all
Abstracts/Posters
- Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple MyelomaTaxiarchis Kourelis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United StatesTaxiarchis Kourelis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain AmyloidosisTaxiarchis Kourelis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- A Proteomic Atlas of Cardiac Amyloidosis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Long-Term Survivorship with Active Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Bortezomib, Lenalidomide and Dexamethasone (VRD) Followed By Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma; The Mayo Clinic Experience2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: